✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹1,331 Cr.
P/E
22.33
About
Bliss GVS Pharma Limited is a prominent pharmaceutical company known for its development, manufacturing, and marketing of high-quality pharmaceutical formulations globally. Specializing in Suppositori… Read more
Bliss GVS Pharma Limited is a prominent pharmaceutical company known for its development, manu… Read more
Low
92
52W Range
High
186
  • Bliss GVS Pharma
  • Lincoln Pharma
  • Jagsonpal Pharma
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Customers
    • Sanofi India Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Alkem Laboratories Ltd.
    • Intas Pharma
    • Mankind Pharma
    FAQs on Bliss GVS Pharma Ltd. Business

    Bliss GVS Pharma Limited is a global leader in Suppositories and Pessaries, offering high-quality pharmaceutical formulations at affordable prices. With a strong presence in over sixty countries, the company is rapidly growing through advancements in R&D, manufacturing, and marketing.

    Bliss GVS Pharma major competitors are Lincoln Pharma, Jagsonpal Pharma, Syncom Formulations, Shivalik Rasayan, Anuh Pharma, Wanbury, Kwality Pharma.
    Market Cap of Bliss GVS Pharma is ₹1,314 Crs.
    While the median market cap of its peers are ₹961 Crs.

    Bliss GVS Pharma seems to be less financially stable compared to its competitors.
    Altman Z score of Bliss GVS Pharma is 5.83 and is ranked 5 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Mar Jun Mar Jun Sep Dec Dec
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material